Theodore C Tarver (Theodore Tarver)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy T Ferng, Daisuke Terada, Makoto Ando, Theodore C Tarver, Fihr Chaudhary, Kimberly C Lin, Aaron C Logan, Catherine C Smith
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms. Molecular cancer therapeutics 21 (5) (2022)
Catherine C Smith, Aaron D Viny, Evan Massi, Cyriac Kandoth, Nicholas D Socci, Franck Rapaport, Matthieu Najm, Juan Santiago Medina-Martinez, Elli Papaemmanuil, Theodore C Tarver, Henry H Hsu, Mai H Le, Brian West, Gideon Bollag, Barry S Taylor, Ross L Levine, Neil P Shah
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Catherine C Smith, Amy Paguirigan, Grace R Jeschke, Kimberly C Lin, Evan Massi, Theodore C Tarver, Chen-Shan Chin, Saurabh Asthana, Adam Olshen, Kevin J Travers, Susana Wang, Mark J Levis, Alexander E Perl, Jerald P Radich, Neil P Shah
Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis. Blood 130 (1) (2017)